Local Tech Wire

DURHAM, N.C. – Charles Johnson, chief medical officer at APT Pharmaceuticals, is joining Inspire Pharmaceuticals (Nasdaq: ISPH) as its CMO as of Sept. 15.

Johnson also will act as Inspire’s executive vice president for research and development.

A 13-year veteran of Genetech, Johnson has more than 30 years of experience in clinical practice, academia and the pharmaceutical industry.

Johnson also is a former director of the cystic fibrosis center at Washington University in St. Louis, Mo. He earned his medical degree in South Africa.

Inspire is actively involved in cystic fibrosis research.

For more about Dr. Johnson,

Get the latest news alerts: at Twitter.